Alfred Aflatooni
Family Medicine · Bremerton, WANPI 1427138510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,196 and has fallen 97.4% since, to $57 in 2021. Among family medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $15.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$506
- AstraZeneca$502
- Pfizer$384
- Amgen$327
- Novartis$272
- Supernus Pharmaceuticals, Inc.$251
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,90999%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $506 |
| AstraZeneca | 25 | $502 |
| Pfizer | 25 | $384 |
| Amgen | 16 | $327 |
| Novartis | 15 | $272 |
| Supernus Pharmaceuticals, Inc. | 29 | $251 |
| Teva Pharmaceuticals USA, Inc. | 16 | $196 |
| Lilly USA, LLC | 15 | $166 |
| Upsher-smith Laboratories LLC | 8 | $131 |
| GSK | 7 | $123 |
| Daiichi Sankyo Inc. | 5 | $117 |
| Boehringer Ingelheim | 5 | $99 |
| Novo Nordisk | 5 | $91 |
| Sunovion Pharmaceuticals Inc. | 7 | $76 |
| Mylan Specialty L.p. | 5 | $72 |
| Bristol Myers Squibb | 4 | $68 |
| Amarin Pharma, Inc. | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $51 |
| Merck | 3 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $46 |
| Circassia Inc. | 3 | $42 |
| Johnson & Johnson | 2 | $42 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| Ironwood Pharmaceuticals, Inc | 2 | $36 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Eisai Inc. | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $14 |
| MDD US Operations, LLC | 1 | $12 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
| Alfasigma USA, Inc. | 1 | $12 |
How this compares
$3,937 in reported general payments places this provider in the 90th percentile of 2,275 family medicine providers in Washington.
Other family medicine in Bremerton
- Matthew SmithBremerton$27K
- Ronald DommermuthBremerton$17K
- Robert CaulkinsBremerton$14K
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
- Marshall BrownPasco$70K
- Cynthia CoteMaple Valley$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.